[1] MATTIOLI S,RUFFATO A,PUMA F,et al.Does anatomical segmentectomy allow an adequate lymph node staging for cT1a non-small cell lung cancer[J].J Thorac Oncol,2011,6(9):1537-1541.
[2] GINSBERG R J,RUBINSTEIN L V.Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer:lung cancer study group[J].Ann Thorac Surg,1995,60(3):615-622;discussion 622-623.
[3] IZBICKI J R,PASSLICK B,PANTEL K,et al.Effectiveness of radical systematic mediastinal lymphadenectomy in patients with resectable non-small cell lung cancer:results of a prospective randomized trial[J].Ann Surg,1998,227(1):138-144.
[4] ASAMURA H,CHANSKY K,CROWLEY J,et al.The international association for the study of lung cancer lung cancer staging project proposals for the revision of the N descriptors in the forthcoming 8th edition of the TNM classification for lung cancer[J].J Thorac Oncol,2015,10(12):1675-1684.
[5] DARLING G E,ALLEN M S,DECKER P A,et al.Randomized trial of mediastinal lymph node sampling versus complete lymphadenectomy during pulmonary resection in the patient with N0 or N1(less than hilar) non-small cell carcinoma:results of the american college of surgery oncology group Z0030 trial[J].J Thorac Cardiovasc Surg,2011,141(3):662-670.
[6] IZBICKI J R,THETTER O,HABEKOST M,et al.Radical systematic mediastinal lymphadenectomy in non-small cell lung cancer:a randomized controlled trial[J].Br J Surg,1994,81(2):229-235.
[7] CHIDA M,MINOWA M,KARUBE Y,et al.Worsened long-term outcomes and postoperative complications in octogenarians with lung cancer following mediastinal lymph-node dissection[J].Interact Cardiovasc Thorac Surg,2009,8(1):89-92.
[8] ALLEN M S,DARLING G E,PECHET T T,et al.Morbidity and mortality of major pulmonary resections in patients with early-stage lung cancer:initial results of the randomized, prospective ACOSOG Z0030 trial[J].Ann Thorac Surg,2006;81(3):1013-1019;discussion 1019-1020.
[9] RUSCH V W,ASAMURA H,WATANABE H,et al.The IASLC lung cancer staging project:a proposal for a new international lymph node map in the forthcoming seventh edition of the TNM classification for lung cancer[J].J Thorac Oncol,2009,4(5):568-577
[10] TRAVIS W D,BRAMBILLA E,NOGUCHI M,et al.International association for the study of lung cancer/american thoracic society/european respiratory society:international multidisciplinary classification of lung adenocarcinoma[J].Proc Am Thorac Soc,2011,8(5):381-385.
[11] TAYLOR L J,JACKSON T L,REID J G,et al.The differentialexpression of oestrogen receptors, progesterone receptors,Bcl-2 and Ki67 in endometrial polyps[J].BJOG,2003,110(9):794-798.
[12] CIANCIO N,GALASSO M G,CAMPISI R,et al.Prognostic value of p53 and Ki67 expression in fiberoptic bronchial biopsies of patients with non small cell lung cancer[J].Multidiscip Respir Med,2012;7(1):29.
[13] RINDI G,WIEDENMANN B.Neuroendocrine neoplasms of the gut and pancreas:new insights[J].Nat Rev Endocrinol,2011,8(1):54-64.
[14] GERDES J,SCHWAB U,LEMKE H,et al. Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation[J].Int J Cancer,1983,31(1):13-20.
[15] BUBB R S,KOMAKI R,HACHIYA T,et al.Association of Ki-67,p53,and bcl-2 expression of the primary non-small-cell lung cancer lesion with brain metastatic lesion[J].Int J Radiat Oncol Biol Phys,2002,53(5):1216-1224.
[16] FONTANINI G,VIGNATI S,CHINE S,et al.67-kilodalton laminin receptor expression correlates with worse prognostic indicators in non-small cell lung carcinomas[J].Clin Cancer Res,1997,3(2):227-231.
[17] CHEN C,ZHU W D,ZHANG X H,et al.Value of Ki-67 and computed tomography in the assessment of peripheral lung adenocarcinoma[J].Br J Biomed Sci,2016,73(1):32-37.
[18] YOSHIZAWA A,MOTOI N,RIELY G J,et al. Impact of proposed IASLC/ATS/ERS classification of lung adenocarcinoma:prognostic subgroups and implications for further revision of staging based on analysis of 514 stage I cases[J].Mod Pathol,2011,24(5):653-664.
[19] NITADORI J,BOGRAD A J,KADOTA K,et al.Impact of micropapillary histologic subtype in selecting limited resection vs lobectomy for lung adenocarcinoma of 2cm or smaller[J].J Natl Cancer Inst,2013,105(16):1212-1220.
[20] MULEY T,DIENEMANN H,EBERT W.CYFRA 21-1 and CEA are independent prognostic factors in 153 operated stage Ⅰ NSCLC patients[J].Anticancer Res,2004,24(3B):1953-1956.
[21] NISMAN B,AMIR G,LAFAIR J,et al. Prognostic value of CYFRA 21-1,TPS and CEA in different histologic types of non-small cell lung cancer[J].Anticancer Res,1999,19(4C):3549-3552.
[22] REINMUTH N,BRANDT B,SEMIK M,et al.Prognostic impact of Cyfra21-1 and other serum markers in completely resected non-small cell lung cancer[J].Lung Cancer,2002,36(3):265-270.
[23] OKADA M,NISHIO W,SAKAMOTO T,et al.Effect of tumor size on prognosis in patients with non-small cell lung cancer:the role of segmentectomy as a type of lesser resection[J].J Thorac Cardiovasc Surg,2005,129(1):87-93.
[24] 张真发,李军,尚文军,等.临床Ⅰ期非小细胞肺癌淋巴结转移的影响因素及临床意义[J].中国肺癌杂志,2003,6(4):298-300.
[25] WATANABE S,ODA M,TSUNEZUKA Y,et al.Peripheral small-sized (2 cm or less) non-small cell lung cancer with mediastinal lymph node metastasis;clinicopathologic features and patterns of nodal spread[J].Eur J Cardiothorac Surg,2002,22(6):995-999. |